The Schall Law Firm is organizing a class action lawsuit targeting Charming Medical Limited (NASDAQ: MCTA) on behalf of investors who purchased securities during a volatile trading period in late October and early November 2025. The litigation addresses allegations of securities fraud stemming from circumstances that led to an SEC trading suspension of the company's shares.
The SEC suspended trading in MCTA shares in November 2025 following a dramatic and unexplained spike in the company's stock price. According to the lawsuit claim, the price movement was allegedly driven by a coordinated promotion scheme involving social media advisors rather than legitimate business developments or financial performance. The SEC action halted trading to protect investors amid the suspicious market activity.
Investors who acquired MCTA securities between October 21, 2025, and November 12, 2025, are eligible to participate in the class action. The Schall Law Firm has set a deadline of February 17, 2026, for interested parties to register their claims. Lead plaintiff positions are available for shareholders seeking to represent the broader class in the litigation.